Free Trial

Acutus Medical (AFIB) Competitors

Acutus Medical logo
$0.06 0.00 (0.00%)
As of 03:44 PM Eastern

AFIB vs. STRR, TTOO, PSTV, PAVM, INBS, TNON, SINT, NUWE, STSS, and HSCS

Should you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Star Equity (STRR), T2 Biosystems (TTOO), Plus Therapeutics (PSTV), PAVmed (PAVM), Intelligent Bio Solutions (INBS), Tenon Medical (TNON), Sintx Technologies (SINT), Nuwellis (NUWE), Sharps Technology (STSS), and Heart Test Laboratories (HSCS). These companies are all part of the "medical equipment" industry.

Acutus Medical vs.

Acutus Medical (NASDAQ:AFIB) and Star Equity (NASDAQ:STRR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

Acutus Medical has a beta of -0.2, indicating that its stock price is 120% less volatile than the S&P 500. Comparatively, Star Equity has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Star Equity'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Star Equity Neutral

Acutus Medical received 9 more outperform votes than Star Equity when rated by MarketBeat users. However, 100.00% of users gave Star Equity an outperform vote while only 32.43% of users gave Acutus Medical an outperform vote.

CompanyUnderperformOutperform
Acutus MedicalOutperform Votes
12
32.43%
Underperform Votes
25
67.57%
Star EquityOutperform Votes
3
100.00%
Underperform Votes
No Votes

Star Equity has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.24-$81.66MN/AN/A
Star Equity$45.78M0.16$25.13M-$2.57-0.86

Star Equity has a net margin of -12.41% compared to Acutus Medical's net margin of -272.74%. Star Equity's return on equity of -8.72% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Star Equity -12.41%-8.72%-4.62%

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 3.8% of Star Equity shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 33.5% of Star Equity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Star Equity beats Acutus Medical on 8 of the 11 factors compared between the two stocks.

Get Acutus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AFIB vs. The Competition

MetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.70M$4.83B$5.39B$9.13B
Dividend YieldN/A52.58%5.37%4.00%
P/E RatioN/A26.8888.8317.53
Price / Sales0.2458.551,284.8780.48
Price / CashN/A50.8936.6032.90
Price / Book-1.907.904.964.69
Net Income-$81.66M$13.87M$117.89M$224.57M
7 Day PerformanceN/A4.15%2.75%3.33%
1 Month PerformanceN/A11.37%3.63%5.33%
1 Year PerformanceN/A33.39%27.26%22.98%

Acutus Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AFIB
Acutus Medical
N/A$0.06
flat
N/A-67.8%$1.70M$7.16M0.00340Gap Down
STRR
Star Equity
N/A$2.19
-1.4%
N/A-53.1%$7.05M$45.78M-0.85460Gap Up
TTOO
T2 Biosystems
1.652 of 5 stars
$0.32
+0.3%
$5.00
+1,457.6%
-94.1%$6.76M$7.68M0.00180Analyst Forecast
News Coverage
Gap Up
PSTV
Plus Therapeutics
2.1129 of 5 stars
$1.13
-2.6%
$13.50
+1,094.7%
-45.6%$6.67M$4.91M-0.4520Positive News
PAVM
PAVmed
4.0165 of 5 stars
$0.60
-1.8%
$19.00
+3,085.2%
-76.1%$6.60M$4.03M-0.1490Positive News
INBS
Intelligent Bio Solutions
1.4557 of 5 stars
$1.30
-2.3%
N/A-66.3%$5.70M$3.19M0.0010Short Interest ↓
News Coverage
Positive News
TNON
Tenon Medical
2.3866 of 5 stars
$1.72
-6.5%
$5.50
+219.8%
+30.7%$5.40M$3.32M-0.068
SINT
Sintx Technologies
0.0532 of 5 stars
$3.30
-2.7%
N/A-94.6%$4.43M$1.64M-0.0740News Coverage
Positive News
Gap Down
NUWE
Nuwellis
2.9289 of 5 stars
$1.01
-1.0%
$17.00
+1,583.2%
-92.2%$4.42M$8.97M-0.0170Positive News
STSS
Sharps Technology
0.8952 of 5 stars
$1.97
-4.4%
N/AN/A$4.03MN/A-0.243
HSCS
Heart Test Laboratories
2.3383 of 5 stars
$3.22
-5.3%
$13.50
+319.3%
-70.8%$3.16M$14,700.00-0.1510Short Interest ↑
Positive News

Related Companies and Tools


This page (NASDAQ:AFIB) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners